Subconjunctival sustained release 5-fluorouracil for glaucoma filtration surgery

Aim: To determine the release characteristics of a 5-fluorouracil-loaded poly (lactic acid) disc (5-FU-PLA-DS) and the effect of sustained drug delivery on the success of glaucoma filtration surgery in rabbit eyes. Methods: A method of microspheres accumulated by excessive carriers was used in the p...

Full description

Saved in:
Bibliographic Details
Published inActa pharmacologica Sinica Vol. 29; no. 9; pp. 1021 - 1028
Main Authors Cui, Li-jun, Sun, Nai-xue, Li, Xing-hua, Huang, Jie, Yang, Jian-gang
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.09.2008
Nature Publishing Group
Subjects
Online AccessGet full text
ISSN1671-4083
1745-7254
1745-7254
DOI10.1111/j.1745-7254.2008.00833.x

Cover

Loading…
Abstract Aim: To determine the release characteristics of a 5-fluorouracil-loaded poly (lactic acid) disc (5-FU-PLA-DS) and the effect of sustained drug delivery on the success of glaucoma filtration surgery in rabbit eyes. Methods: A method of microspheres accumulated by excessive carriers was used in the preparation of the 5-FU-PLA-DS. The disc was characterized for drug loading, entrapment efficiency, in vitro release, and external morphology. It was then implanted subconjunctivally into rabbit eyes with trabeculectomy. Intraocular pressure, ocular inflammatory reaction, filtration bleb appearance, and persistence were evaluated up to postoperative d 90. A quantitative analysis of 5-fluorouracil (5-FU) was performed in the aqueous humor. Ultrasound biomicroscopy was used to assess the appearance of the filtering fistula. Results: The 5-FU-PLA-DS was produced with the drug-loading of 3.07±0.08 mg (mean±SD). 5-FU was released for 91 d with suppressive concentrations. The decrease in intraocular pressure from baseline was significantly more marked in the 5-FU-PLA-DSimplanted eyes during postoperative d 3-90, and the persistence of bleb and filtration fistula was longer than the control eyes (P〈0.05). Corneal toxicity and hyperemia triggered by 5-FU was lower in the 5-FU-PLA-DS-implanted eyes than those exposed to 5-FU intraoperatively. The 5-FU concentration in the aqueous humor was insufficient for corneal endothelial damage. No evidence of toxic reaction was found in the conjunctival biopsy. Conclusion: 5-FU-PLA- DS displaying sustained intraocular release of 5-FU, reduced intraocular pressure, and prolonged bleb persistence, while significantly reducing 5-FU toxicity.
AbstractList Aim: To determine the release characteristics of a 5-fluorouracil-loaded poly (lactic acid) disc (5-FU-PLA-DS) and the effect of sustained drug delivery on the success of glaucoma nitration surgery in rabbit eyes. Methods: A method of microspheres accumulated by excessive carriers was used in the preparation of the 5-FU-PLA-DS. The disc was characterized for drug loading, entrapment efficiency, in vitro release, and external morphology. It was then implanted sub-conjunctivally into rabbit eyes with trabeculectomy. Intraocular pressure, ocular inflammatory reaction, filtration bleb appearance, and persistence were evaluated up to postoperative d 90. A quantitative analysis of 5-fluorouracil (5-FU) was performed in the aqueous humor. Ultrasound biomicroscopy was used to assess the appearance of the filtering fistula. Results: The 5-FU-PLA-DS was produced with the drug-loading of 3.07 plus or minus 0.08 mg (mean plus or minus SD). 5-FU was released for 91 d with suppressive concentrations. The decrease in intraocular pressure from baseline was significantly more marked in the 5-FU-PLA-DS-implanted eyes during postoperative d 3-90, and the persistence of bleb and filtration fistula was longer than the control eyes (P<0.05). Corneal toxicity and hyperemia triggered by 5-FU was lower in the 5-FU-PLA-DS-implanted eyes than those exposed to 5-FU intraoperatively. The 5-FU concentration in the aqueous humor was insufficient for corneal endothelial damage. No evidence of toxic reaction was found in the conjunctival biopsy. Conclusion: 5-FU-PLA-DS displaying sustained intraocular release of 5-FU, reduced intraocular pressure, and prolonged bleb persistence, while significantly reducing 5-FU toxicity.
To determine the release characteristics of a 5-fluorouracil-loaded poly (lactic acid) disc (5-FU-PLA-DS) and the effect of sustained drug delivery on the success of glaucoma filtration surgery in rabbit eyes.AIMTo determine the release characteristics of a 5-fluorouracil-loaded poly (lactic acid) disc (5-FU-PLA-DS) and the effect of sustained drug delivery on the success of glaucoma filtration surgery in rabbit eyes.A method of microspheres accumulated by excessive carriers was used in the preparation of the 5-FU-PLA-DS. The disc was characterized for drug loading, entrapment efficiency, in vitro release, and external morphology. It was then implanted subconjunctivally into rabbit eyes with trabeculectomy. Intraocular pressure, ocular inflammatory reaction, filtration bleb appearance, and persistence were evaluated up to postoperative d 90. A quantitative analysis of 5-fluorouracil (5-FU) was performed in the aqueous humor. Ultrasound biomicroscopy was used to assess the appearance of the filtering fistula.METHODSA method of microspheres accumulated by excessive carriers was used in the preparation of the 5-FU-PLA-DS. The disc was characterized for drug loading, entrapment efficiency, in vitro release, and external morphology. It was then implanted subconjunctivally into rabbit eyes with trabeculectomy. Intraocular pressure, ocular inflammatory reaction, filtration bleb appearance, and persistence were evaluated up to postoperative d 90. A quantitative analysis of 5-fluorouracil (5-FU) was performed in the aqueous humor. Ultrasound biomicroscopy was used to assess the appearance of the filtering fistula.The 5-FU-PLA-DS was produced with the drug-loading of 3.07+/-0.08 mg (mean+/-SD). 5-FU was released for 91 d with suppressive concentrations. The decrease in intraocular pressure from baseline was significantly more marked in the 5-FU-PLA-DSimplanted eyes during postoperative d 3-90, and the persistence of bleb and filtration fistula was longer than the control eyes (P<0.05). Corneal toxicity and hyperemia triggered by 5-FU was lower in the 5-FU-PLA-DS-implanted eyes than those exposed to 5-FU intraoperatively. The 5-FU concentration in the aqueous humor was insufficient for corneal endothelial damage. No evidence of toxic reaction was found in the conjunctival biopsy.RESULTSThe 5-FU-PLA-DS was produced with the drug-loading of 3.07+/-0.08 mg (mean+/-SD). 5-FU was released for 91 d with suppressive concentrations. The decrease in intraocular pressure from baseline was significantly more marked in the 5-FU-PLA-DSimplanted eyes during postoperative d 3-90, and the persistence of bleb and filtration fistula was longer than the control eyes (P<0.05). Corneal toxicity and hyperemia triggered by 5-FU was lower in the 5-FU-PLA-DS-implanted eyes than those exposed to 5-FU intraoperatively. The 5-FU concentration in the aqueous humor was insufficient for corneal endothelial damage. No evidence of toxic reaction was found in the conjunctival biopsy.5-FU-PLADS displaying sustained intraocular release of 5-FU, reduced intraocular pressure, and prolonged bleb persistence, while significantly reducing 5-FU toxicity.CONCLUSION5-FU-PLADS displaying sustained intraocular release of 5-FU, reduced intraocular pressure, and prolonged bleb persistence, while significantly reducing 5-FU toxicity.
Aim: To determine the release characteristics of a 5-fluorouracil-loaded poly (lactic acid) disc (5-FU-PLA-DS) and the effect of sustained drug delivery on the success of glaucoma filtration surgery in rabbit eyes. Methods: A method of microspheres accumulated by excessive carriers was used in the preparation of the 5-FU-PLA-DS. The disc was characterized for drug loading, entrapment efficiency, in vitro release, and external morphology. It was then implanted subconjunctivally into rabbit eyes with trabeculectomy. Intraocular pressure, ocular inflammatory reaction, filtration bleb appearance, and persistence were evaluated up to postoperative d 90. A quantitative analysis of 5-fluorouracil (5-FU) was performed in the aqueous humor. Ultrasound biomicroscopy was used to assess the appearance of the filtering fistula. Results: The 5-FU-PLA-DS was produced with the drug-loading of 3.07±0.08 mg (mean±SD). 5-FU was released for 91 d with suppressive concentrations. The decrease in intraocular pressure from baseline was significantly more marked in the 5-FU-PLA-DSimplanted eyes during postoperative d 3-90, and the persistence of bleb and filtration fistula was longer than the control eyes (P〈0.05). Corneal toxicity and hyperemia triggered by 5-FU was lower in the 5-FU-PLA-DS-implanted eyes than those exposed to 5-FU intraoperatively. The 5-FU concentration in the aqueous humor was insufficient for corneal endothelial damage. No evidence of toxic reaction was found in the conjunctival biopsy. Conclusion: 5-FU-PLA- DS displaying sustained intraocular release of 5-FU, reduced intraocular pressure, and prolonged bleb persistence, while significantly reducing 5-FU toxicity.
To determine the release characteristics of a 5-fluorouracil-loaded poly (lactic acid) disc (5-FU-PLA-DS) and the effect of sustained drug delivery on the success of glaucoma filtration surgery in rabbit eyes. A method of microspheres accumulated by excessive carriers was used in the preparation of the 5-FU-PLA-DS. The disc was characterized for drug loading, entrapment efficiency, in vitro release, and external morphology. It was then implanted subconjunctivally into rabbit eyes with trabeculectomy. Intraocular pressure, ocular inflammatory reaction, filtration bleb appearance, and persistence were evaluated up to postoperative d 90. A quantitative analysis of 5-fluorouracil (5-FU) was performed in the aqueous humor. Ultrasound biomicroscopy was used to assess the appearance of the filtering fistula. The 5-FU-PLA-DS was produced with the drug-loading of 3.07+/-0.08 mg (mean+/-SD). 5-FU was released for 91 d with suppressive concentrations. The decrease in intraocular pressure from baseline was significantly more marked in the 5-FU-PLA-DSimplanted eyes during postoperative d 3-90, and the persistence of bleb and filtration fistula was longer than the control eyes (P<0.05). Corneal toxicity and hyperemia triggered by 5-FU was lower in the 5-FU-PLA-DS-implanted eyes than those exposed to 5-FU intraoperatively. The 5-FU concentration in the aqueous humor was insufficient for corneal endothelial damage. No evidence of toxic reaction was found in the conjunctival biopsy. 5-FU-PLADS displaying sustained intraocular release of 5-FU, reduced intraocular pressure, and prolonged bleb persistence, while significantly reducing 5-FU toxicity.
Aim: To determine the release characteristics of a 5-fluorouracil-loaded poly (lactic acid) disc (5-FU-PLA-DS) and the effect of sustained drug delivery on the success of glaucoma filtration surgery in rabbit eyes. Methods: A method of microspheres accumulated by excessive carriers was used in the preparation of the 5-FU-PLA-DS. The disc was characterized for drug loading, entrapment efficiency, in vitro release, and external morphology. It was then implanted subconjunctivally into rabbit eyes with trabeculectomy. Intraocular pressure, ocular inflammatory reaction, filtration bleb appearance, and persistence were evaluated up to postoperative d 90. A quantitative analysis of 5-fluorouracil (5-FU) was performed in the aqueous humor. Ultrasound biomicroscopy was used to assess the appearance of the filtering fistula. Results: The 5-FU-PLA-DS was produced with the drug-loading of 3.07±0.08 mg (mean±SD). 5-FU was released for 91 d with suppressive concentrations. The decrease in intraocular pressure from baseline was significantly more marked in the 5-FU-PLA-DS-implanted eyes during postoperative d 3-90, and the persistence of bleb and filtration fistula was longer than the control eyes ( P <0.05). Corneal toxicity and hyperemia triggered by 5-FU was lower in the 5-FU-PLA-DS-implanted eyes than those exposed to 5-FU intraoperatively. The 5-FU concentration in the aqueous humor was insufficient for corneal endothelial damage. No evidence of toxic reaction was found in the conjunctival biopsy. Conclusion: 5-FU-PLA-DS displaying sustained intraocular release of 5-FU, reduced intraocular pressure, and prolonged bleb persistence, while significantly reducing 5-FU toxicity.
To determine the release characteristics of a 5-fluorouracil-loaded poly (lactic acid) disc (5-FU-PLA-DS) and the effect of sustained drug delivery on the success of glaucoma filtration surgery in rabbit eyes. A method of microspheres accumulated by excessive carriers was used in the preparation of the 5-FU-PLA-DS. The disc was characterized for drug loading, entrapment efficiency, in vitro release, and external morphology. It was then implanted subconjunctivally into rabbit eyes with trabeculectomy. Intraocular pressure, ocular inflammatory reaction, filtration bleb appearance, and persistence were evaluated up to postoperative d 90. A quantitative analysis of 5-fluorouracil (5-FU) was performed in the aqueous humor. Ultrasound biomicroscopy was used to assess the appearance of the filtering fistula. The 5-FU-PLA-DS was produced with the drug-loading of 3.07+/-0.08 mg (mean+/-SD). 5-FU was released for 91 d with suppressive concentrations. The decrease in intraocular pressure from baseline was significantly more marked in the 5-FU-PLA-DSimplanted eyes during postoperative d 3-90, and the persistence of bleb and filtration fistula was longer than the control eyes (P<0.05). Corneal toxicity and hyperemia triggered by 5-FU was lower in the 5-FU-PLA-DS-implanted eyes than those exposed to 5-FU intraoperatively. The 5-FU concentration in the aqueous humor was insufficient for corneal endothelial damage. No evidence of toxic reaction was found in the conjunctival biopsy. 5-FU-PLADS displaying sustained intraocular release of 5-FU, reduced intraocular pressure, and prolonged bleb persistence, while significantly reducing 5-FU toxicity.
Author Li-jun CUI Nai-xue SUN Xing-hua LI Jie HUANG Jian-gang YANG
AuthorAffiliation Departments of Ophthalmologv Xi-an Jiaotong University, Xi-an 710004, China Departments of Pharmacology, Xi-an Jtaotong Universty, Xi-an 710004, China
Author_xml – sequence: 1
  givenname: Li-jun
  surname: Cui
  fullname: Cui, Li-jun
  organization: Department of Ophthalmology, Xi-an Jiaotong University
– sequence: 2
  givenname: Nai-xue
  surname: Sun
  fullname: Sun, Nai-xue
  email: nxsun_xju@126.com
  organization: Department of Ophthalmology, Xi-an Jiaotong University
– sequence: 3
  givenname: Xing-hua
  surname: Li
  fullname: Li, Xing-hua
  organization: Department of Pharmacology, Xi-an Jiaotong University
– sequence: 4
  givenname: Jie
  surname: Huang
  fullname: Huang, Jie
  organization: Department of Pharmacology, Xi-an Jiaotong University
– sequence: 5
  givenname: Jian-gang
  surname: Yang
  fullname: Yang, Jian-gang
  organization: Department of Ophthalmology, Xi-an Jiaotong University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/18718170$$D View this record in MEDLINE/PubMed
BookMark eNqFkUtLxTAQhYMovv-CFBfuWjNJ2qZLEV8gKKjrkKbptTU30aSR67839QluDIQE5pvDnDk7aN06qxHKABeQzvFYQM3KvCYlKwjGvEiX0mK1hrZ_CuvpX9WQs1TaQjshjBhTQqHZRFvAa-BQ4210exdb5ewYrZqGV2myEMMkB6u7zGujZdBZmfcmOu-il2owWe98tjAyKreUWT-YyctpcDY1-oX2b3too5cm6P2vdxc9nJ_dn17m1zcXV6cn17mijE15TTW0QHBPO9qSRknWdiC5qkpgXad70D1RwIBVPSGagWyA1IrXDaaStorTXXT0qfvs3UvUYRLLIShtjLTaxSCqhpXJIvkXJIAJL2FWPPwDjsmzTSYSQzEhDaUJOviCYrvUnXj2w1L6N_G90QQ0n0BIJZs28qsCWMzpiVHMIYk5JDGnJz7SE6vfCdSjs4uX1C5aqZ7SkrUgnFXJEKfv5-qY2g
Cites_doi 10.1016/j.jconrel.2004.05.002
10.1016/j.addr.2005.09.007
10.1016/0005-2736(93)90398-J
10.1016/j.jconrel.2006.12.028
10.1136/bjo.2004.040055
10.1001/archopht.1990.01070050128046
10.1136/bjo.84.1.92
10.1016/j.ijpharm.2007.02.001
10.1016/S0039-6257(03)00038-9
10.2165/00003495-200767020-00005
10.1016/S0002-9394(14)72443-2
10.1001/archopht.1988.01060130886046
10.1097/01.ijg.0000151684.12033.4d
10.1016/S0886-3350(01)01069-0
10.1089/jop.1989.5.155
10.1002/jps.20591
10.1111/j.1600-0420.2006.00810.x
ContentType Journal Article
Copyright CPS and SIMM 2008
Copyright Nature Publishing Group Sep 2008
Copyright_xml – notice: CPS and SIMM 2008
– notice: Copyright Nature Publishing Group Sep 2008
DBID 2RA
92L
CQIGP
W91
~WA
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QP
7QR
7T5
7TK
7TO
7U9
7X7
7XB
88E
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7N
M7P
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7QO
7X8
DOI 10.1111/j.1745-7254.2008.00833.x
DatabaseName 维普期刊资源整合服务平台
中文科技期刊数据库-CALIS站点
中文科技期刊数据库-7.0平台
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Immunology Abstracts
Neurosciences Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Biotechnology Research Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Algology Mycology and Protozoology Abstracts (Microbiology C)
Health & Medical Research Collection
Biological Science Collection
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
Biotechnology Research Abstracts
MEDLINE - Academic
DatabaseTitleList Engineering Research Database
MEDLINE - Academic

ProQuest Central Student

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
DocumentTitleAlternate Subconjunctival sustained release 5-fluorouracil for glaucoma filtration surgery
EISSN 1745-7254
EndPage 1028
ExternalDocumentID 1730259941
18718170
10_1111_j_1745_7254_2008_00833_x
28465818
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-05
-0E
-Q-
-SE
-S~
.3N
0R~
188
1OC
23M
2RA
2WC
31~
36B
3V.
4.4
406
53G
5GY
5VR
5VS
6J9
70F
7X7
8-1
88E
8FI
8FJ
8R4
8R5
8RM
92L
92M
9D9
9DE
A8Z
AACDK
AANZL
AASML
AATNV
AAWBL
AAXDM
AAZLF
ABAKF
ABAWZ
ABKZE
ABUWG
ABZZP
ACAOD
ACGFO
ACGFS
ACIWK
ACKTT
ACMJI
ACPRK
ACRQY
ACXQS
ACZOJ
ADBBV
ADFRT
ADHDB
ADRAZ
AEFQL
AEJRE
AEMSY
AENEX
AESKC
AEVLU
AEXYK
AFBBN
AFBPY
AFKRA
AFRAH
AFSHS
AFUIB
AFZJQ
AGAYW
AGEZK
AGHAI
AGQEE
AHMBA
AHSBF
AIGIU
AILAN
AJAOE
AJRNO
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMYLF
AOIJS
AXYYD
BAWUL
BBNVY
BENPR
BFHJK
BHPHI
BKKNO
BPHCQ
BVXVI
C1A
CAG
CAJEE
CCEZO
CCPQU
CHBEP
CIEJG
CO8
COF
CQIGP
CS3
CW9
DIK
DNIVK
DPUIP
E3Z
EBLON
EBS
EE.
EIOEI
EJD
EMB
EMOBN
F5P
FA0
FDQFY
FERAY
FIGPU
FIZPM
FSGXE
FYUFA
GX1
HCIFZ
HH5
HMCUK
HYE
HZI
HZ~
IWAJR
JSO
JUIAU
JZLTJ
K97
KQ8
LGEZI
LH4
LOTEE
LW6
M1P
M48
M7P
MK0
NADUK
NQJWS
NXXTH
O9-
OK1
OVD
P2P
P6G
PQQKQ
PROAC
PSQYO
Q--
Q-4
Q2X
R-E
RNT
RNTTT
ROL
RPM
RT5
S..
SNX
SNYQT
SOHCF
SRMVM
SV3
SWTZT
T8U
TAOOD
TBHMF
TDRGL
TEORI
TR2
TSG
U1F
U1G
U5E
U5O
UKHRP
UZ5
W91
~88
~NG
~WA
ABBRH
ABDBE
ABFSG
ABRTQ
ACSTC
AEZWR
AFDZB
AFHIU
AHWEU
AIXLP
ATHPR
AYFIA
CGR
CUY
CVF
ECM
EIF
NPM
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
SOJ
7QP
7QR
7T5
7TK
7TO
7U9
7XB
8FD
8FE
8FH
8FK
AZQEC
DWQXO
FR3
GNUQQ
H94
K9.
LK8
M7N
P64
PKEHL
PQEST
PQUKI
PRINS
7QO
7X8
ACMFV
ID FETCH-LOGICAL-c344t-73e1b120f3d3b29ca4bd1a8c6514ddef1ef2c14146f22e41a9127c87903a3bc83
IEDL.DBID 7X7
ISSN 1671-4083
1745-7254
IngestDate Fri Jul 11 04:58:32 EDT 2025
Tue Aug 05 10:49:24 EDT 2025
Sat Aug 23 13:57:27 EDT 2025
Mon Jul 21 06:06:51 EDT 2025
Fri Feb 21 02:38:49 EST 2025
Tue Jan 07 06:29:55 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords 5-fluorouracil
polymer
intraocular pressure
sustained release
glaucoma
rabbit
microsphere
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c344t-73e1b120f3d3b29ca4bd1a8c6514ddef1ef2c14146f22e41a9127c87903a3bc83
Notes 5-fluorouracil; polymer; microsphere; sustained release; glaucoma; intraocular pressure; rabbit
5-fluorouracil
polymer
intraocular pressure
sustained release
glaucoma
rabbit
microsphere
R96
31-1347/R
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 18718170
PQID 213022933
PQPubID 28815
PageCount 8
ParticipantIDs proquest_miscellaneous_69458172
proquest_miscellaneous_21028518
proquest_journals_213022933
pubmed_primary_18718170
springer_journals_10_1111_j_1745_7254_2008_00833_x
chongqing_backfile_28465818
PublicationCentury 2000
PublicationDate 2008-09-01
PublicationDateYYYYMMDD 2008-09-01
PublicationDate_xml – month: 09
  year: 2008
  text: 2008-09-01
  day: 01
PublicationDecade 2000
PublicationPlace London
PublicationPlace_xml – name: London
– name: United States
– name: Shanghai
PublicationTitle Acta pharmacologica Sinica
PublicationTitleAbbrev Acta Pharmacol Sin
PublicationTitleAlternate Acta Pharmacologica Sinica
PublicationYear 2008
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Sastre, Olmo, Teijón, Muñiz, Teijón, Blanco (CR14) 2007; 338
Tahery, Lee (CR3) 1989; 5
Hitzman, Elmquist, Wattenberg, Wiedmann (CR10) 2006; 95
Fraser (CR8) 2004; 88
Aksungur, Sungur, Unal, Iskit, Squier, Senel (CR11) 2004; 98
Lee, Leong, Panek, Eng, Glasgow (CR18) 1988; 29
Heller (CR20) 2005; 57
Collignon (CR1) 2005; 295
Huang, Zhu, Liu, Chen, Liu, Chang (CR16) 2005; 24
Jampel, Leong, Dunkelburger, Quigley (CR21) 1990; 108
Pandey, Cochener, Apple, Colin, Werner, Bougaran (CR13) 2002; 28
Einmahl, Behar-Cohen, D'Hermies, Rudaz, Tabatabay, Re-nard (CR19) 2001; 42
Joshi, Parrish, Feuer (CR5) 2005; 14
Wilkins, Occleston, Kotecha, Waters, Khaw (CR26) 2000; 84
Lama, Fechtner (CR2) 2003; 48
Abraham, Selva, Casson, Leibovitch (CR6) 2007; 67
CR4
Elorza, Elorza, Frutos, Chantres (CR9) 1993; 1153
Hasty, Heuer, Minckler (CR22) 1990; 109
Blandford, Smith, Brown, Pearson, Ashton (CR17) 1992; 33
Khaw, Word, Porter, Grierson, Hitchings, Rice (CR24) 1992; 33
Mannis, Sweet, Lewis (CR25) 1988; 106
Gao, Gu, Ping (CR12) 2007; 118
Moritera, Ogura, Honda, Wada, Hyon, Ikada (CR15) 1991; 32
Lee, Shapourifar, Kitada (CR23) 1990; 31
Sisto, Vetrugno, Trabucco, Cantatore, Ruggeri, Sborgia (CR7) 2007; 85
References_xml – volume: 98
  start-page: 269
  year: 2004
  end-page: 79
  ident: CR11
  article-title: Chito-san delivery systems for the treatment of oral mucositis: and studies.
  publication-title: J Control Release
  doi: 10.1016/j.jconrel.2004.05.002
– volume: 57
  start-page: 2053
  year: 2005
  end-page: 62
  ident: CR20
  article-title: Ocular delivery using poly(ortho esters).
  publication-title: Adv Drug Deliv Rev
  doi: 10.1016/j.addr.2005.09.007
– volume: 33
  start-page: 2043
  year: 1992
  end-page: 52
  ident: CR24
  article-title: The long-term effects of 5-fluorourocil and sodium butyrate on human tenon's fibroblasts.
  publication-title: Invest Ophthalmol Vis Sci
– volume: 1153
  start-page: 135
  year: 1993
  end-page: 42
  ident: CR9
  article-title: Characterization of 5-fluorouracil loaded liposomes prepared by reverse-phase evaporation or freezing-thawing extrusion methods: study of drug release.
  publication-title: Biochim Biophys Acta
  doi: 10.1016/0005-2736(93)90398-J
– volume: 118
  start-page: 325
  year: 2007
  end-page: 32
  ident: CR12
  article-title: The implantable 5-fluorouracil-loaded poly(l-lactic acid) fibers prepared by wet-spinning from suspension.
  publication-title: J Control Release
  doi: 10.1016/j.jconrel.2006.12.028
– ident: CR4
– volume: 33
  start-page: 3430
  year: 1992
  end-page: 5
  ident: CR17
  article-title: Subcon-junctival sustained release 5-fluorouracil.
  publication-title: Invest Ophthalmol Vis Sci
– volume: 88
  start-page: 855
  year: 2004
  end-page: 6
  ident: CR8
  article-title: Trabeculectomy and antimetabolites.
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.2004.040055
– volume: 108
  start-page: 430
  year: 1990
  end-page: 5
  ident: CR21
  article-title: Glaucoma filtration surgery in monkeys using 5-fluorouridine in polyanhydride discs.
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.1990.01070050128046
– volume: 84
  start-page: 92
  year: 2000
  end-page: 7
  ident: CR26
  article-title: Sponge delivery variables and tissue levels of 5-fluorouracil.
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.84.1.92
– volume: 338
  start-page: 180
  year: 2007
  end-page: 90
  ident: CR14
  article-title: 5-Fluorouracil plasma levels and biodegradation of subcutane-ously injected drug-loaded microspheres prepared by spray-drying poly( -lactide) and poly( -lactide-co-glycolide) polymers.
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2007.02.001
– volume: 48
  start-page: 314
  year: 2003
  end-page: 46
  ident: CR2
  article-title: Antifibrotics and wound healing in glaucoma surgery.
  publication-title: Surv Ophthalmol
  doi: 10.1016/S0039-6257(03)00038-9
– volume: 31
  start-page: 1848
  year: 1990
  end-page: 55
  ident: CR23
  article-title: The effect of 5-fluorouracil and cytarabine on human fibroblasts from Tenon's capsule.
  publication-title: Invest Ophthalmol Vis Sci
– volume: 67
  start-page: 237
  year: 2007
  end-page: 55
  ident: CR6
  article-title: The clinical applications of fluorouracil in ophthalmic practice.
  publication-title: Drugs
  doi: 10.2165/00003495-200767020-00005
– volume: 32
  start-page: 1785
  year: 1991
  end-page: 90
  ident: CR15
  article-title: Micro-spheres of biodegradable polymers as a drug-delivery system in the vitreous.
  publication-title: Invest Ophthalmol Vis Sci
– volume: 109
  start-page: 721
  year: 1990
  end-page: 5
  ident: CR22
  article-title: Primate trabeculectomies with 5-fluorouracil collagen implants.
  publication-title: Am J Ophthalmol
  doi: 10.1016/S0002-9394(14)72443-2
– volume: 29
  start-page: 1692
  year: 1988
  end-page: 7
  ident: CR18
  article-title: The use of bioerodible polymer and 5-fluorouracil in glaucoma filtering surgery.
  publication-title: Invest Ophthalmol Vis Sci
– volume: 106
  start-page: 816
  year: 1988
  end-page: 7
  ident: CR25
  article-title: The effect of fluorouracil on the corneal endothelium.
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.1988.01060130886046
– volume: 24
  start-page: 1023
  year: 2005
  end-page: 6
  ident: CR16
  article-title: Preparation and release efficiency of polylactic acid nanoparticle.
  publication-title: Ai Zheng
– volume: 14
  start-page: 172
  year: 2005
  end-page: 4
  ident: CR5
  article-title: 2002 survey of the American Glaucoma Society: practice preferences for glaucoma surgery and antifibrotic use.
  publication-title: J Glaucoma
  doi: 10.1097/01.ijg.0000151684.12033.4d
– volume: 295
  start-page: 55
  year: 2005
  end-page: 9
  ident: CR1
  article-title: Wound healing after glaucoma surgery: how to manage it?
  publication-title: Bull Soc Belge Ophtalmol
– volume: 28
  start-page: 139
  year: 2002
  end-page: 48
  ident: CR13
  article-title: Intracapsular ring sustained 5-fluorouracil delivery system for the prevention of posterior capsule opacification in rabbits: a histo-logical study.
  publication-title: J Cataract Refract Surg
  doi: 10.1016/S0886-3350(01)01069-0
– volume: 5
  start-page: 155
  year: 1989
  end-page: 79
  ident: CR3
  article-title: Pharmacologic control of wound healing in glaucoma filtration surgery.
  publication-title: J Ocul Pharmacol
  doi: 10.1089/jop.1989.5.155
– volume: 95
  start-page: 1114
  year: 2006
  end-page: 26
  ident: CR10
  article-title: Development of a respirable, sustained release microcarrier for 5-fluorouracil I: assessment of liposomes, microspheres, and lipid coated nanoparticles.
  publication-title: J Pharm Sci
  doi: 10.1002/jps.20591
– volume: 85
  start-page: 267
  year: 2007
  end-page: 71
  ident: CR7
  article-title: The role of antimetabolites in filtration surgery for neovascular glaucoma: intermediate-term follow-up.
  publication-title: Acta Ophthalmol Scand
  doi: 10.1111/j.1600-0420.2006.00810.x
– volume: 42
  start-page: 695
  year: 2001
  end-page: 700
  ident: CR19
  article-title: A new poly(ortho ester)-based drug delivery system as an adjunct treatment in filtering surgery.
  publication-title: Invest Ophthalmol Vis Sci
SSID ssj0032319
Score 1.9563137
Snippet Aim: To determine the release characteristics of a 5-fluorouracil-loaded poly (lactic acid) disc (5-FU-PLA-DS) and the effect of sustained drug delivery on the...
Aim: To determine the release characteristics of a 5-fluorouracil-loaded poly (lactic acid) disc (5-FU-PLA-DS) and the effect of sustained drug delivery on the...
To determine the release characteristics of a 5-fluorouracil-loaded poly (lactic acid) disc (5-FU-PLA-DS) and the effect of sustained drug delivery on the...
Aim: To determine the release characteristics of a 5-fluorouracil-loaded poly (lactic acid) disc (5-FU-PLA-DS) and the effect of sustained drug delivery on the...
SourceID proquest
pubmed
springer
chongqing
SourceType Aggregation Database
Index Database
Publisher
StartPage 1021
SubjectTerms 5-氟脲嘧啶
Animals
Antimetabolites - administration & dosage
Antimetabolites - therapeutic use
Aqueous Humor - drug effects
Aqueous Humor - metabolism
Biomedical and Life Sciences
Biomedicine
Chromatography, High Pressure Liquid
Conjunctiva
Delayed-Action Preparations
Drug Carriers
Drug Compounding
Female
Fluorouracil - administration & dosage
Fluorouracil - therapeutic use
Glaucoma
Glaucoma Drainage Implants
Immunology
Indicators and Reagents
Internal Medicine
Intraocular Pressure - drug effects
Lactic Acid
Medical Microbiology
Microspheres
Ophthalmologic Surgical Procedures
original-article
Particle Size
Pharmacology/Toxicology
Polyglycolic Acid
Prosthesis Implantation
Rabbits
Spectrophotometry, Ultraviolet
Survival Analysis
Vaccine
微球
眼内压
聚合物
青光眼
SummonAdditionalLinks – databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3JTsMwELUQXLggdsrqA-LUVPGS7YAQQlQICdQDlXqLbMdmi1LoItG_Z6ZJWpbC2U4cjcd-bzIbIadKq1A5X3tcuNADhNZekgWBl4HhBuwVGImbBsjehzddedsLekukTlesBDhcaNphP6nuIG99vE8u4MCff4vKwaas5U8SDI6MhWgBs1wBfIrwuN7JmW9BAKNBUszCCK2nWPyM71nwJiy88NQvHt8BThZR0V9u1Ck6tdfJWkUr6WWpBxtkyRab5KxT1qWeNOnDPM1q2KRntDOvWD3ZIh24PsAufgGMw25nOR2WaVU2o9hTBYCOBp7Lx_0BrKPMc06B6lIg3mPQV0Xdc14V34UHp1nW26Tbvn64uvGqVgueEVKOvEhYphn3nciE5olRUmdMxSYEPgUXoGPWccMkXKuOcyuZShiPTBwlvlBCm1jskOWiX9g9lKXSOtFWqMBIplUcuCTLfIWGXCSMa5CDmSwBqs0rFqBKASWBC7EYRmvpprUypBy9q8BLRIOczEbhGKBvQxW2P8YpQJQCfP6vGWEiYYGIN8huuWnpW1nPI2VgNGKdwgbh9S7O1_5iJIFqpKgaVetOVI30Y__fDz4gq3WAic8OyfJoMLZHwGJG-niqlJ8wYOzQ
  priority: 102
  providerName: Scholars Portal
Title Subconjunctival sustained release 5-fluorouracil for glaucoma filtration surgery
URI http://lib.cqvip.com/qk/95561A/20089/28465818.html
https://link.springer.com/article/10.1111/j.1745-7254.2008.00833.x
https://www.ncbi.nlm.nih.gov/pubmed/18718170
https://www.proquest.com/docview/213022933
https://www.proquest.com/docview/21028518
https://www.proquest.com/docview/69458172
Volume 29
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LSwMxEA4-DnoR39ZHzUF6Mrh57OskKooIShELvS1JNpFq2aptQf-9M7vbVnwdlyRkyczO983OZIaQI210pH1gmJA-YoDQhqV5GLIcHDdgr8BIfJkgexddd9RNN-zWuTnDOq1yYhNLQ50PLP4jPxEYYQNskqcvrwybRmFwte6gMU8WsXIZZnTF3am_JYG6IPvlUYxuUiK_J_JgH9fqvwrmUyZSYv2jJbA6xeMr4MZvnPNHvLSEoatVslLzR3pWCXyNzLlinbTaVQHqj2P6MLtPNTymLdqelab-2CBtsBPgAD8BmGFbsz4dVvenXE6xeQogGg2Z748Hb7CPtr0-BU5LgWGP4ZA09b1-XWUXFpbXqTdJ5-ry4eKa1T0VmJVKjVgsHTdcBF7m0ojUamVyrhMbAXECS-e588JyBfbTC-EU1ykXsU3iNJBaGpvILbJQDAq3g2epjUmNkzq0ihudhD7N80CjxxZL6xtkb3qWgMn2GStNZQCHQHp4AqOT083qz2aYTYXcIIfTUdB3DGLowg3GOAUYUYjr_5oRpQo2iEWDbFdCy16qwh0ZB-8QCxI2iJhIcbb3F28IVCND1ah7dKJqZO-7_77wHlmeZJIEfJ8sjN7G7gDoysg0S6VsksXzy7v2PTzdquQTmPjqdg
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxEB6V9FAuiHdDgfoAPdVi_djXAVW0tEppiSKUSr0tttdGhWjTNokgP6r_kZnsboJ43Xq2vV7NjGe-8YxnAF4ZaxITIsulCglHC215XsYxL9FxQ_SKiCQsEmT7Se9MfziPz9fgpn0LQ2mVrU5cKOpy7OiO_I2kCBvaJrV3ecWpaRQFV9sOGrVUnPj5d_TYJm-P3yN7X0t5dDg86PGmqQB3SuspT5UXVsgoqFJZmTujbSlM5hJEDnjUg_BBOqFRgQQpvRYmFzJ1WZpHyijrMoXfvQPrWqEn04H1_cP-4FOr-hWCJcLbIknJMcvU76lD1Dm2vsmhDM5MKaq4tIF6rvpyhZbqbyj3jwjtwvAd3Yd7DWJl72oRewBrvnoIO4O65PV8lw1XL7gmu2yHDVbFsOePYICaCV3ur2g-qZHaiE3qF1u-ZNSuBW0oi3kYzcbXuI9xFyOGKJohpp8hWwwLF6Omri8uXDzgfgxnt0LwJ9CpxpXfJFoaa3PrlYmdFtZkccjLMjLkI6bKhS5sLWmJKMB9o9pWBRpghFkiw9GWukVzUCfFUqy6sL0cxRNGYRNT-fGMpiAGi2n9v2YkucYNUtmFpzXTisu6VEgh0B-lEohdkC0XV3v_4n-haBQkGk1XUBKN4sez__7wNmz0hh9Pi9Pj_skW3G3zWCLxHDrT65l_gWBpal82Isrg822fip_O2iY6
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxEB6VIJVeKh4F0gD1AXqq1bW9zwNCiBK1pIpyaKXcFttrV4Vo0zaJSn4a_46ZfSSoPG49216vxvP4xp4HwFttdKx9YLhUPuZooQ3PiijiBTpuiF4RkfgqQHYYH5-HX8bReAN-trkwFFbZ6sRKURdTS3fkh5Je2NA2qUPfREWMjvofrq45NZCih9a2m0bNIQO3vEXvbfb-5AiP-p2U_c9nn45502CAWxWGc54oJ4yQgVeFMjKzOjSF0KmNEUWg2HvhvLQiRGXipXSh0JmQiU2TLFBaGZsq_O4DeJioSJCIJeOVr6cQNhHyFnFCLlqq7gYRUQ_Z-k6HYjlTpaj20iPUeOXFNdqsv-HdP95qKxPYfwzbDXZlH2tmewIbrnwK-6O6-PXygJ2tc7lmB2yfjdZlsZfPYIQ6Cp3vb2hIqaXahM3q3C1XMGrcgtaURdxPFtMb3EfbywlDPM0Q3S_wgDTzl5Omwi8urFK5d-D8Xsj9HDrltHQviZbamMw4pSMbCqPTyGdFEWjyFhNlfRd6K1oiHrDfqcpVjqYYAZdIcbSlbt6I7CxfMVgX9lajKGv0gKJLN13QFERjEa3_14w4C3GDRHbhRX1o-VVdNCQX6JlSMcQuyPYU13v_5okha-TEGk1_UGKN_Mfuf394DzZRFvLTk-GgB1ttQEsgXkFnfrNwrxE1zc2bij8ZfL1vgfgFXPspCg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Subconjunctival+sustained+release+5-fluorouracil+for+glaucoma+filtration+surgery&rft.jtitle=Acta+pharmacologica+Sinica&rft.au=Cui%2C+Li-jun&rft.au=Sun%2C+Nai-xue&rft.au=Li%2C+Xing-hua&rft.au=Huang%2C+Jie&rft.date=2008-09-01&rft.pub=Nature+Publishing+Group&rft.issn=1671-4083&rft.eissn=1745-7254&rft.volume=29&rft.issue=9&rft.spage=1021&rft_id=info:doi/10.1111%2Fj.1745-7254.2008.00833.x&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=1730259941
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F95561A%2F95561A.jpg